Company

InnoCan Pharma Corp

Headquarters: Calgary, AB, Canada

CEO: Ms. Iris Bincovich

OTC: INNPF

Market Cap

$58.1 Million

USD as of July 1, 2024

Market Cap History

InnoCan Pharma Corp market capitalization over time

Evolution of InnoCan Pharma Corp market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of InnoCan Pharma Corp

Detailed Description

InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment by using CBD loaded exosomes; and CBD loaded liposomes. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is based in Calgary, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

InnoCan Pharma Corp has the following listings and related stock indices.


Stock: OTC: INNPF wb_incandescent

Stock: CSE: INNO wb_incandescent

Stock: FSX: IP4 wb_incandescent

Details

Headquarters:

1015, 926 - 5 Avenue SW

Calgary, AB T2P 0N7

Canada